Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Peer Review reports

From: The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival

Original Submission
26 Nov 2003 Submitted Original manuscript
5 Jan 2004 Reviewed Reviewer Report - Torgny Rasmuson
10 Mar 2004 Author responded Author comments - Michael Bergqvist
Resubmission - Version 2
10 Mar 2004 Submitted Manuscript version 2
13 Apr 2004 Reviewed Reviewer Report - Gunnar Hillerdal
14 Apr 2004 Reviewed Reviewer Report - Torgny Rasmuson
Resubmission - Version 3
Submitted Manuscript version 3
5 May 2004 Author responded Author comments - Michael Bergqvist
Resubmission - Version 4
5 May 2004 Submitted Manuscript version 4
2 Jun 2004 Reviewed Reviewer Report - Torgny Rasmuson
Resubmission - Version 5
Submitted Manuscript version 5
26 Jul 2004 Author responded Author comments - Michael Bergqvist
Resubmission - Version 6
26 Jul 2004 Submitted Manuscript version 6
Publishing
14 Sep 2004 Editorially accepted
14 Sep 2004 Article published 10.1186/1471-2407-4-66

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us